ヘルスケア株
| # | 過去7日 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1694 |  ELVN Enliven Therapeutics, Inc. - Common Stock | 39.33 USD | +0.13% | -4.07% | -20.88% | +90.37% | 2.88 B USD | ||
| 1699 |  DYN Dyne Therapeutics, Inc. - Common Stock | 15.29 USD | +1.66% | -6.83% | -14.58% | -34.69% | 2.86 B USD | ||
| 1720 |  AVAH Aveanna Healthcare Holdings Inc. - Common Stock | 12.64 USD | +2.27% | +3.27% | -11.79% | +28.06% | 2.76 B USD | ||
| 1728 |  NRIX Nurix Therapeutics, Inc. - Common stock | 24.95 USD | +5.41% | +13.20% | -3.26% | +122.57% | 2.73 B USD | ||
| 1743 |  NEOG Neogen Corporation - Common Stock | 12.27 USD | +1.15% | +4.78% | -3.76% | +109.39% | 2.68 B USD | ||
| 1752 |  TMDX TransMedics Group, Inc. - Common Stock | 76.52 USD | +1.32% | -3.30% | -13.05% | -32.48% | 2.65 B USD | ||
| 1760 |  ZLAB Zai Lab Limited - American Depositary Shares | 23.51 USD | +4.49% | -5.28% | -6.89% | -11.91% | 2.64 B USD | ||
| 1772 |  PGEN Precigen, Inc. - Common Stock | 7.20 USD | -2.17% | -4.38% | -5.14% | +111.76% | 2.58 B USD | ||
| 1779 |  BEAM Beam Therapeutics Inc. - Common Stock | 24.73 USD | +4.57% | +0.04% | +1.85% | -2.83% | 2.55 B USD | ||
| 1791 |  GRDN Guardian Pharmacy Services, Inc. Class A Common Stock | 39.66 USD | -2.24% | -4.39% | -15.56% | +22.60% | 2.51 B USD | ||
| 1796 |  CLOV Clover Health Investments, Corp. - Class A Common stock | 4.68 USD | -2.30% | -9.30% | +2.63% | +76.60% | 2.49 B USD | ||
| 1800 |  NAMS NewAmsterdam Pharma Company N.V. - Ordinary Shares | 20.62 USD | +3.05% | -3.01% | -4.63% | -43.15% | 2.46 B USD | ||
| 1805 |  MBX MBX Biosciences, Inc. - Common Stock | 50.71 USD | +3.87% | -4.79% | -18.86% | +273.42% | 2.44 B USD | ||
| 1808 |  HCM HUTCHMED (China) Limited - American Depositary Shares | 13.94 USD | +3.41% | +0.58% | +2.50% | -8.23% | 2.43 B USD | ||
| 1814 |  BKD Brookdale Senior Living Inc. Common Stock | 10.10 USD | -0.20% | -2.42% | -13.75% | +16.90% | 2.41 B USD | ||
| 1818 |  ADMA ADMA Biologics Inc - Common Stock | 10.73 USD | +3.77% | +3.97% | +18.56% | -25.64% | 2.40 B USD | ||
| 1831 |  BHC Bausch Health Companies Inc. Common Stock | 6.32 USD | +7.12% | +3.78% | +9.34% | +5.33% | 2.36 B USD | ||
| 1841 |  PBH Prestige Consumer Healthcare Inc. Common Stock | 49.23 USD | +1.80% | +3.69% | +3.66% | -20.11% | 2.33 B USD | ||
| 1848 |  UFPT UFP Technologies, Inc. - Common Stock | 297.19 USD | +2.09% | +3.99% | +6.33% | +46.25% | 2.30 B USD | ||
| 1849 |  SUPN Supernus Pharmaceuticals, Inc. - Common Stock | 39.57 USD | -1.52% | -6.19% | -5.02% | -26.72% | 2.30 B USD |
ニュース ヘルスケア株
UBS、Solid Biosciencesのカバレッジを開始、投資判断は「買い」、目標株価20ドルを発表
MacroGenics、進行固形腫瘍患者を対象とした、非開示標的に向けた抗体薬物複合体MGC030の第1相試験で最初の患者への投与を開始
木曜日の取引中に動いたヘルスケア株12銘柄
Dyadic Internationalの13G提出書類は、Empery Asset Managementが9月30日時点で同社株式8.35%を保有していると報告していることを示す
NeurAxis、医療ポリシーの適用対象が2,600万人超の医療保険加入者に拡大したと発表
Edesa Biotech、尋常性白斑におけるEB06の第2相臨床試験に関する治験薬（IND）申請についてFDAの承認を取得
Wedbush、Sutro Biopharmaの「アウトパフォーム」を再確認、目標株価60ドルを維持
上昇銘柄ヘルスケア株
 ESLA Estrella Immunopharma, Inc. - Common Stock | 0.54 | +68.75% |
 DRMA Dermata Therapeutics, Inc. - Common Stock | 0.91 | +37.88% |
 INDP Indaptus Therapeutics, Inc. - Common Stock | 2.85 | +28.96% |
 HUMA Humacyte, Inc. - Common Stock | 0.44 | +25.71% |
 NMRA Neumora Therapeutics, Inc. - Common Stock | 0.43 | +22.86% |
 PIIIW P3 Health Partners Inc. - Warrant | 0.0072 | +20.00% |
 TRIB Trinity Biotech plc - American Depositary Shares each represent | 7.93 | +19.97% |
 AKTX Akari Therapeutics Plc - American Depositary Shares | 8.67 | +19.75% |
下落銘柄ヘルスケア株
 SPRC SciSparc Ltd. - Ordinary Shares | 2.00 | -44.75% |
 CDIOW Cardio Diagnostics Holdings Inc. - Warrant | 0.0064 | -28.09% |
 NXGLW NexGel, Inc - Warrant | 0.0065 | -27.78% |
 DRTSW Alpha Tau Medical Ltd. - Warrant | 2.9900 | -17.40% |
 PFSA Profusa, Inc. - Common Stock | 1.07 | -16.41% |
 MDAIW Spectral AI, Inc. - Warrants | 0.4100 | -16.33% |
 CDTTW CDT Equity Inc. - Warrant | 0.0061 | -15.28% |
 PTN Palatin Technologies, Inc. Common Stock | 6.49 | -15.27% |